These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2024366)

  • 41. Ureterosigmoidostomy: the development of tumors, diagnosis, and pitfalls.
    Princenthal RA; Lowman R; Zeman RK; Burrell M
    AJR Am J Roentgenol; 1983 Jul; 141(1):77-81. PubMed ID: 6602534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone demineralization following ureterosigmoid anastomosis: an experimental study in rats.
    Koch MO; McDougal WS
    J Urol; 1988 Oct; 140(4):856-9. PubMed ID: 3418822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colonic adenocarcinoma: a late complication of ureterosigmoidostomy.
    McFadden DD; Himal HS
    Can Med Assoc J; 1982 Apr; 126(7):827. PubMed ID: 7074477
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sigmoid carcinoma as a long-term complication following ureterosigmoidostomy].
    Bredenoord AJ; Onaca MG; van Ramshorst B; Biesma DH
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):213-5. PubMed ID: 18320948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysplasia of ureteric epithelium: a source of adenocarcinoma in ureterosigmoidostomy?
    Aaronson IA; Sinclair-Smith CC
    Z Kinderchir; 1984 Dec; 39(6):364-7. PubMed ID: 6524086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The intake of nitrate, nitrite and volatile N-nitrosamines and the occurrence of volatile N-nitrosamines in human urine and veal calves.
    Stephany RW; Schuller PL
    IARC Sci Publ (1971); 1978; (19):443-60. PubMed ID: 680737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenocarcinoma at ureterosigmoidostomy junction in a renal transplant recipient 15 years after conversion to ileal conduit.
    Weinstein T; Zevin D; Kyzer S; Korzets A; Halperin M; Luria B; Levi J
    Clin Nephrol; 1995 Aug; 44(2):125-7. PubMed ID: 8529301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ureterosigmoidostomy.
    Spirnak JP; Caldamone AA
    Urol Clin North Am; 1986 May; 13(2):285-94. PubMed ID: 3515726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-nitrosamine formation in urinary-tract infections.
    Ohshima H; Calmels S; Pignatelli B; Vincent P; Bartsch H
    IARC Sci Publ; 1987; (84):384-90. PubMed ID: 3679407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Severe hypopotassemia 50 years after bilateral ureterosigmoidostomy intervention. Clinical and physiopathologic considerations].
    Pingi C; Potestà P
    Recenti Prog Med; 1986 Dec; 77(12):561-4. PubMed ID: 3563084
    [No Abstract]   [Full Text] [Related]  

  • 51. Role of vitamin E as nitrite scavenger and N-nitrosamine inhibitor: a review.
    Lathia D; Blum A
    Int J Vitam Nutr Res; 1989; 59(4):430-8. PubMed ID: 2699323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelial interaction in carcinogenesis complicating ureterosigmoidostomy.
    Schumacher K; Vogel J; Miersch WD; Wagner U
    Investig Urol (Berl); 1994; 5():236-8. PubMed ID: 7719313
    [No Abstract]   [Full Text] [Related]  

  • 53. Measurement of endogenous n-nitrosation in rats and humans by monitoring urinary and faecal excretion of N-nitrosamino acids.
    Ohshima H; Bereziat JC; Bartsch H
    IARC Sci Publ; 1982; (41):397-411. PubMed ID: 7141546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The natural history of tumors in oncogenesis after ureterosigmoidostomy. II--Experimental approach].
    Daher N; Abourachid H; Bara J
    J Urol (Paris); 1989; 95(3):139-41. PubMed ID: 2664001
    [No Abstract]   [Full Text] [Related]  

  • 55. Secondary malignancies in different forms of urinary diversion using isolated gut.
    Austen M; Kälble T
    J Urol; 2004 Sep; 172(3):831-8. PubMed ID: 15310979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ureterosigmoidostomy and carcinoma of the colon.
    Pierce EH; Zickerman P; Leadbetter GW
    Trans Am Assoc Genitourin Surg; 1978; 70():92-8. PubMed ID: 223267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased urinary nitrosamine excretion in paraplegic patients.
    Tricker AR; Stickler DJ; Chawla JC; Preussmann R
    Carcinogenesis; 1991 May; 12(5):943-6. PubMed ID: 2029761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formation of N-mononitrosopiperazine in the stomach and its excretion in the urine after oral intake of piperazine.
    Bellander T; Osterdahl BG; Hagmar L
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):193-8. PubMed ID: 4024110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Excretion of N-mononitrosopiperazine after low level exposure to piperazine in air: effects of dietary nitrate and ascorbate.
    Bellander T; Osterdahl BG; Hagmar L
    Toxicol Appl Pharmacol; 1988 Apr; 93(2):281-7. PubMed ID: 3358264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of vitamin E to prevent nitrosamine formation.
    Mergens WJ
    Ann N Y Acad Sci; 1982; 393():61-9. PubMed ID: 6959571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.